ArticlePhysics and imaging in radiation oncology2026
CT image generation from ultrashort echo time MRI for dosimetric assessment in lung cancer radiotherapy.
Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: To facilitate magnetic resonance imaging (MRI)-only radiotherapy workflows and overcome the lack of electron density information in MRI for accurate radiotherapy dose calculation, we proposed a cycle-consistent generative adversarial network-based framework, Fast Fourier Transform Spatial-Channel Net (FFTSC-Net). This study aimed to synthesize high-quality synthetic computed tomography (sCT) from lung ultrashort echo time-MRI (UTE-MRI) and assess its potential clinical dosimetric viability. Materials and methods: UTE-MRI and CT data from 60 patients with lung cancer were retrospectively collected and spatially aligned through deformable registration. FFTSC-Net was developed by integrating spatial and channel reconstruction convolution, squeeze-and-excitation, and residual fast Fourier transform modules, alongside a dual contrastive loss function. The synthesis quality was evaluated using structural similarity index (SSIM), peak signal-to-noise ratio (PSNR), and mean absolute error (MAE). The clinical feasibility was assessed through Hounsfield unit (HU) consistency analysis in organs at risk (OARs) and planning target volume (PTV), dose volume histogram parameters, and gamma passing rates. Results: FFTSC-Net achieved an SSIM of 0.80, PSNR of 20.07 dB, and MAE (HU) of 59.31. No statistically significant differences were observed in HU distributions for lungs, spinal cord, and PTV compared with planning CT ( Conclusion: FFTSC-Net demonstrates high image fidelity and dosimetric accuracy, supporting its potential for MRI-only radiotherapy planning in patients with lung cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.